NVG-291 — Topline data
H1 2028
NervGen anticipates completing enrollment in the second half of 2027 and reporting topline data in the first half of 2028.Source filing
NGEN biotech catalysts & pipeline
NERVGEN PHARMA CORP · Data as of 2026-10-25
catalyst calendar
/